TGen identified gene that could explain disparity in COVID-19 effects
On Dec. 15, 2020, TGen, an affiliate of City of Hope announced that it had identified a specific…
-
-
AXIM Biotechnologies completed successful Covid-19 live virus test and filed amended EUA
On Dec. 15, 2020, AXIM Biotechnologies announced the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based…
-
INOVIO to develop DNA-encoded monoclonal antibody (dMAb) candidates to treat COVID-19
On Dec. 15, 2020, Inovio Pharma announced the company and a team of scientists from The Wistar Institute,…
-
RedHill’s phase 2/3 COVID-19 candidate opaganib reduced ARDS-related blood clotting in preclinical model
On Dec. 15, 2020, a months long study to determine the number of Houstonians carrying COVID-19 antibodies revealed…
-
Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccine
On Dec. 14, 2020, Codagenix and the Serum Institute of India announced that a Phase 1 clinical trial…
-
U.S. Dept of Veterans Affairs began COVID-19 vaccinations
On Dec. 14, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that the New Orleans and Bedford,…
-
FDA approved first-of-its-kind Intentional genomic alteration in Line of domestic pigs for human food, potential therapeutic uses
On Dec. 14, 2020, the U.S. Food and Drug Administration (FDA) approved the a first-of-its-kind intentional genomic alteration…
-
No association found between COVID-19 and Guillain-Barre syndrome
On Dec.14, 2020, neuroscientists at University College London (UCL) announced they had found no significant association between COVID-19…
-
Incyte announced results of phase 3 study of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 associated cytokine storm
On Dec. 14, 2020, Incyte announced that the Phase 3 RUXCOVID study evaluating the safety and efficacy of…
-
FDA approved first intentional genomic alteration in domestic pigs for both human food, potential therapeutic uses
On Dec. 14, 2020, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in…
-
Moderna confirmed supply agreement to supply Singapore with mRNA vaccine against COVID-19
On Dec. 14, 2020, Moderna confirmed that the Company had concluded an agreement with the Ministry of Health…
-
Antibody study suggested COVID-19 infections underestimated
On Dec. 14, 2020, a months long study to determine the number of Houstonians carrying COVID-19 antibodies revealed…
-
Data from phase 1/2 study further characterized immune response with lead COVID-19 vaccine candidate
On Dec. 14, 2020, Pfizer and BioNTech announced additional data on neutralizing antibody and T cell responses from…
-
Biotechnology | CRISPR | FDA | Therapeutics
CIRM-funded project targeting sickle cell disease received green light for clinical trial
On Dec.14, 2020, the US Food and Drug Administration (FDA) announced they had granted Investigational New Drug (IND)…
-
Novartis updated on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
On Dec. 14, 2020, Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard…
-
Anixa Biosciences Covid-19 therapy demonstrated comparable potency to remdesivir in pre-clinical testing
On Dec. 14, 2020, Anixa Biosciences announced that it and partner OntoChem GmbH had verified that one of…
-
CDC’s ACIP issued interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged =16 years for prevention of COVID-19.
On Dec. 12, 2020, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of…
-
CDC recommended vaccination with Pfizer and BioNTech COVID-19 vaccine for ages 16 years and older
On Dec. 12, 2020, Pfizer and BioNTech announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) voted…
-
Amarin reported encouraging efficacy and safety results from VASCEPA pilot study treating COVID-19 infected outpatients
On Dec. 12, 2020, Amarin announced clinical results from the CardioLink-9 Trial, the first results of a study…
-
AstraZeneca acquired Alexion Corp for $39 billion
On Dec. 12, 2020, AstraZeneca and Alexion Pharmaceuticals announced an agreement for AstraZeneca to acquire Alexion. Alexion shareholders…
-
AI test ruled out a COVID-19 diagnosis within one hour in Emergency Departments
On Dev. 11, 2020, the University of Oxford reported that an Artificial Intelligence test had been shown to…
-
Baricitinib plus remdesivir showed promise for treating COVID-19
On Dec. 11, 2020, the combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to…
-
US FDA issued Emergency Use Authorization for first COVID-19 vaccine
On Dec. 11, 2020, the FDA issued the first emergency use authorization (EUA) for a vaccine for the…
-
USDA confirmed COVID-19 in a snow leopard at a Kentucky zoo
On Dec. 11, 2020, the USDA’s National Veterinary Services Laboratories announced the first confirmed case of SARS-CoV-2 (the…
-
UK COVID-19 infections survey revealed changes to pandemic over time
On Dev. 11, 2020, the University of Oxford reported that data from the National COVID-19 Infection Survey, done…
-
U.S. Government exercised 1st option for additional 100 million doses of Moderna’s COVID-19 vaccine
On Dec. 11, 2020, Moderna announced that the U.S. government has exercised its option to purchase an additional…
-
COVID-19 | FDA | Therapeutics
Data from ACTT-2 trial of Baricitinib in hospitalized COVID-19 patients supportive of the EUA published in NEJM
On Dec. 11, 2020, Eli Lilly and Incyte announced The New England Journal of Medicine had published the…
-
GABA-enriched tomato first CRISPR-edited food to enter market launched in Japan
On Dec. 11, 2020, Sanatech Seed Co, and sales partner Pioneer EcoScience, announced the commercial sales of Sicilian…
-
European CHMP adopted positive opinion for HEPLISAV-Bﾮ hepatitis B adjuvanted vaccine
On Dec. 10, 2020, Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for…
-
Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
On Dec. 10, 2020, Roche announced a partnership with Moderna to utilise the Elecsys Anti-SARS-CoV-2 S antibody test…
